Xianhui H. Ruan
Department Of Thyroid And Neck Cancer, Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300060, China
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
A novel tetramethylpyrazine derivative inhibits thyroid cancer progression by epigenetically activating the DUSP19-mediated JNK signaling pathway.
Journal: Acta biochimica et biophysica Sinica
Published: May 18, 2026
Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer.
Journal: Investigational new drugs
Published: May 05, 2026
A comparative analysis of hemithyroidectomy and total thyroidectomy in sporadic medullary thyroid carcinoma
Journal: Zhonghua yi xue za zhi
Published: March 08, 2026
PRDM16 Drives Thyroid Cancer Differentiation via a TRIM58-MVP Axis to Suppress MAPK and PI3K/AKT Signaling.
Journal: International journal of biological sciences
Published: January 08, 2026
Risk factors for postoperative recurrence of thyroid cancer patients in children, adolescents, and young adults.
Journal: Translational pediatrics
Published: December 03, 2025
SUV39H2-mediated NCOA4 methylation controls ferritinophagy and ferroptosis in triple-negative breast cancer.
Journal: Cell death & disease
Published: October 28, 2025
Multi-Omics-Based Characterization of DNA Methylation Episignatures for Papillary Thyroid Cancer in a Chinese Population.
Journal: Thyroid : official journal of the American Thyroid Association
Published: May 29, 2025
Integrative Multi-Omics Analysis Reveals Key Metabolic Regulators and Prognostic Biomarkers in Pediatric and Adult Thyroid Cancer.
Journal: Journal of Cancer
Published: May 06, 2025
Keratin 6A Overexpression in the Lymphovascular Invasion-Associated Tumor Subgroup Promotes Progression of Triple-Negative Breast Cancer.
Journal: Cancer research and treatment
Published: April 17, 2025
Enhancer-mediated NR2F2 recruitment activates BGN to promote tumor growth and shape tumor microenvironment in papillary thyroid cancer.
Journal: Theranostics
Published: March 13, 2025
Identification of stemness subtypes and prognostic modeling in thyroid cancer: the critical role of DPYSL3 in tumor progression and immune microenvironment.
Journal: Discover oncology
Published: March 05, 2025
Last Updated: 09/26/2026